Antigen Discovery Inc (ADI) is a biomarker discovery company that offers research services and products using high throughput protein microarray technology. The company provides products such as protein microarrays, elisa, human proteome microarray, soluble proteome, and others. It provides services such as expert statistical analysis, proteome screening; vaccine development and efficacy monitoring, diagnostic content discovery, biomarker discovery and drug validation, among others. ADI’s proteomics approach enables the identification of proteins useful for the development of a wide range of therapeutics, vaccines, diagnostics, and others. The company partners with pharmaceutical and biotechnology companies, universities, medical centers, and consortiums working in the areas of infectious disease and vaccine development. ADI is headquartered in Irvine, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Antigen Discovery Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Antigen Discovery Inc Company Overview
- Antigen Discovery Inc Company Snapshot
- Antigen Discovery Inc Pipeline Products and Ongoing Clinical Trials Overview
- Antigen Discovery Inc - Pipeline Analysis Overview
- Antigen Discovery Inc - Key Facts
- Antigen Discovery Inc - Major Products and Services
- Antigen Discovery Inc Pipeline Products by Development Stage
- Antigen Discovery Inc Pipeline Products Overview
- ELISA Based Rapid Test - COVID-19
- ELISA Based Rapid Test - COVID-19 Product Overview
- Microfluidic Point of Care Device
- Microfluidic Point of Care Device Product Overview
- Pan-Proteome Microarray Test - Syphilis
- Pan-Proteome Microarray Test - Syphilis Product Overview
- POC Test - COVID-19/Influenza
- POC Test - COVID-19/Influenza Product Overview
- Serodiagnostic Assay - YFV
- Serodiagnostic Assay - YFV Product Overview
- Vaccine Mediated Protection Diagnostic Test
- Vaccine Mediated Protection Diagnostic Test Product Overview
- Antigen Discovery Inc - Key Competitors
- Antigen Discovery Inc - Key Employees
- Antigen Discovery Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Antigen Discovery Inc, Recent Developments
- Feb 15, 2017: Discovery of biomarkers associated with 100% protection by PfSPZ-CVac against malaria published in Nature
- Aug 15, 2012: Antigen Discovery Receives Phase I SBIR Grant To Develop Fully Integrated Microfluidic Point Of Care Diagnostic Device
- Aug 13, 2012: Antigen Discovery receives Phase II SBIR grant to identify biomarkers associated with protection against malaria
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Antigen Discovery Inc Pipeline Products and Ongoing Clinical Trials Overview
- Antigen Discovery Inc Pipeline Products by Equipment Type
- Antigen Discovery Inc Pipeline Products by Indication
- Antigen Discovery Inc, Key Facts
- Antigen Discovery Inc, Major Products and Services
- Antigen Discovery Inc Number of Pipeline Products by Development Stage
- Antigen Discovery Inc Pipeline Products Summary by Development Stage
- ELISA Based Rapid Test - COVID-19 - Product Status
- ELISA Based Rapid Test - COVID-19 - Product Description
- Microfluidic Point of Care Device - Product Status
- Microfluidic Point of Care Device - Product Description
- Pan-Proteome Microarray Test - Syphilis - Product Status
- Pan-Proteome Microarray Test - Syphilis - Product Description
- POC Test - COVID-19/Influenza - Product Status
- POC Test - COVID-19/Influenza - Product Description
- Serodiagnostic Assay - YFV - Product Status
- Serodiagnostic Assay - YFV - Product Description
- Vaccine Mediated Protection Diagnostic Test - Product Status
- Vaccine Mediated Protection Diagnostic Test - Product Description
- Antigen Discovery Inc, Key Employees
- Glossary
- Antigen Discovery Inc Pipeline Products by Equipment Type
- Antigen Discovery Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Antibody Solutions Inc
- Research Foundation for Mental Hygiene Inc
- Juvaris BioTherapeutics Inc
- Golden Helix Inc
